Imipenem and Cilastatin

Imipenem and Cilastatin, PRIMAXIN

Penem Antibacterial

NADAC/unit N/A

No Shortage Tier 1: 40.1% PA Req: 13.4% 2 Manufacturers 3 ANDAs

Covered Lives

Active Shortages

2026-01-08 To be discontinued in approximately mid-2026., Merck Sharp & Dohme Corp.

Generic Manufacturers

ACS DOBFAR SPAHQ SPECIALTY PHARMA CORPMERCK AND CO INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Imipenem and Cilastatin drfinder.aiFind doctors who prescribe Imipenem and Cilastatin rxnews.aiLatest news about Imipenem and Cilastatin

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.